BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

Bio Usawa and Rwanda Development Board Partner to Launch First Eye Treatment Manufacturing Plant in Rwanda

Bio Usawa and the Rwanda Development Board have partnered to establish Rwanda’s first manufacturing plant for affordable treatments for serious eye...

November 22, 2024 | News

GBI Biomanufacturing Expands Services with Automated Sterile Fill-Finish Capabilities

GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expa...

November 21, 2024 | News

Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...

November 20, 2024 | News

SEKISUI Diagnostics Completes £15.7 Million cGMP Expansion for Enhanced Microbial Drug Substance Manufacturing in the UK

SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion&nbs...

November 15, 2024 | News

Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility

In an exclusive interview with BioPharma APAC, Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZ...

November 15, 2024 | Interview

Australia’s Aravax Establishes UK Subsidiary to Advance Allergy Immunotherapies

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today an...

November 14, 2024 | News

Ascend Advanced Therapies Partners with EW Healthcare to Bolster US Footprint and Integrate ABL’s Expertise in Viral Vector Manufacturing

Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capa...

November 13, 2024 | News

Lonza Expands Bioconjugation Capabilities in Switzerland with New Manufacturing Suites

The expansion of bioconjugation capabilities will provide additional manufacturing capacity for launch and commercial supply, addressing growing market...

November 12, 2024 | News

Aditum Bio and Leads Biolabs Launch Oblenio Bio to Advance First-in-Class Tri-Specific Antibody for Autoimmune Diseases

Aditum Bio and Leads Biolabs announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreeme...

November 08, 2024 | News

AstraZeneca to Create Over 800 Jobs in Singapore with New $1.5 Billion Facility for Precision Cancer Therapies

AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global su...

November 08, 2024 | News

Vitrian Invests $50M in AmplifyBio’s Manufacturing Enablement Center, Driving Biomanufacturing Growth in Central Ohio

-Vitrian, the leading end-to-end provider of investment capital and capacity building services for biomanufacturing, announced that it closed a $50 million...

November 06, 2024 | News

Ring Therapeutics Partners with Singapore's A*STAR and SERI to Drive R&D in Ophthalmology, Oncology, and Bioprocessing

Wide-ranging A*STAR and SERI partnership will accelerate the development of novel developmental candidates in the areas of ophthalmology and onco...

November 06, 2024 | News

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Merck Invests €70 Million to Triple ADC Manufacturing Capacity at St. Louis Facility, Bolstering Bioconjugation Excellence

Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...

October 30, 2024 | News

Stay Connected